Clinical Trials Browser

Phase 1/2 × Malignant Solid Tumor × pembrolizumab × Clear all

NCT06391775 2025-12-26

Trial to Assess the Safety and Preliminary Efficacy of GEN1055 on Malignant Solid Tumors as Monotherapy and as Combination Therapy

Phase 1/2 Terminated

Other solid neoplasm

Malignant Solid Tumor